Publications by authors named "Junliang Fu"

Claim this Profile
S
Significant histologic alterations in untreated chronic hepatitis B children: a meta-analysis.
Chenyang Huang, Xin Guo, Ziwei Wang, Yuefei Pan, Qiyu Jiang, Junliang Fu, Fu-Sheng Wang

BMC Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning model for HBsAg seroclearance after 48-week pegylated interferon therapy in inactive HBsAg carriers: a retrospective study.
Jianxia Dong, Shan Ren, Jing Zhao, Pengxuan Wu, Haitian Yu, Junliang Fu

Virol J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD300A CD8 T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon-Alpha Therapy.
Peng Zhang, Wen-Xin Wang, Jing Li, Qiaolan Lv, Meng-Meng Zhu, Fu-Sheng Wang, Junliang Fu

Aliment Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.
Hongmin Wang, Xiaoying Li, Junfeng Lu, Xin Zhang, Shuangsuo Dang, Fu-Sheng Wang, Junliang Fu

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis.
Shan Ren, Sujun Zheng, Xinyang Zhang, Junliang Fu, Rongshan Fan

Virol J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights.
Lei Shi, Ziying Zhang, Song Mei, Zerui Wang, Zhe Xu, Jun-Liang Fu, Fu-Sheng Wang

Signal Transduct Target Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A research protocol for a prospective, multicenter, cohort study on interferon therapy for chronic hepatitis B combined with metabolism-associated fatty liver disease to achieve clinical cure.
Daqiong Zhou, Chao Zhang, Lu Zhang, Jianru Jia, Junliang Fu

Front Public Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and Dynamic MAF-5 Score to Predict Liver Fibrosis and Liver-Related Events in General Population With MASLD.
Shanghao Liu, Xuanwei Jiang, Junliang Fu, Vincent Wai-Sun Wong, Victor W Zhong

Clin Gastroenterol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial.
Meng-Qi Yuan, Le Song, Ze-Rui Wang, Zi-Ying Zhang, Ming Shi, Jun-Liang Fu, Fu-Sheng Wang

Stem Cell Res Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Clinical Indicators and Liver Pathology in Children with Chronic Hepatitis B.
Chenyang Huang, Ying Lu, Ziwei Wang, Qiyu Jiang, Yi Dong, Fuchuan Wang, Junliang Fu, Fu-Sheng Wang

Biomedicines· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and phase I studies of an antisense oligonucleotide drug targeting in liver cancer.
Yonggang Li, Zhe Xu, Yuanyuan Li, Tianjun Jiang, Fanping Meng, Junliang Fu, Fusheng Wang

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B.
Wen-Xin Wang, Xiaoyan Li, Xue-Yuan Jin, Rui Jia, Hong-Min Wang, Fu-Sheng Wang, Junliang Fu

ILIVER· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.
Zhiqian Feng, Junliang Fu, Lili Tang, Chunmei Bao, Honghong Liu, Fu-Sheng Wang

Hepatol Int· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study.
Xiaoyan Li, Shanghao Liu, Ying Guo, Hongmei Zu, Huiling Xiang, Wei Fu, Fu-Sheng Wang, Junliang Fu

MedComm (2020)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China.
Chuan Liu, Liting Zhang, Shuairan Zhang, Xiaoguo Li, Yu-Jun Wong, Junliang Fu

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak.
Shaohua Zhang, Lili Tang, Chunmei Bao, Siyu Wang, Bo Li, Junliang Fu, Fu-Sheng Wang

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study.
Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, Huan-Yue Wen, Peng-Hui Yang, Junliang Fu, Fu-Sheng Wang

Signal Transduct Target Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC.
Maojun You, Yanan Gao, Junliang Fu, Runze Xie, Zhenyu Zhu, Fu-Sheng Wang

Hepatology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial.
Tian-Tian Li, Bo Zhang, Hui Fang, Ming Shi, Wei-Qi Yao, Jun-Liang Fu, Fu-Sheng Wang

EBioMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients.
Wen-Xin Wang, Rui Jia, Xue-Yuan Jin, Xiaoyan Li, Shuang-Nan Zhou, Fu-Sheng Wang, Junliang Fu

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased granzyme-B expression in CD11cCD8 T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma.
Lin Gao, Zhixian Hong, Guanglin Lei, An-Liang Guo, Fu-Sheng Wang, Junliang Fu

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Methylprednisolone on Mortality and Clinical Courses in Patients with Severe COVID-19: A Propensity Score Matching Analysis.
Xiaoyan Li, Xin Yuan, Zhe Xu, Lei Shi, Lei Huang, Junliang Fu

Infect Dis Immun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19.
Xiaoyan Li, Xin Yuan, Zhe Xu, Lei Huang, Lei Shi, Fu-Sheng Wang, Junliang Fu

Infect Med (Beijing)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy.
Wen-Xin Wang, Rui Jia, Jin-Wen Song, Xiaoning Zhang, Shuang-Nan Zhou, Fu-Sheng Wang, Junliang Fu

Front Microbiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients.
Wen-Xin Wang, Rui Jia, Ying-Ying Gao, Jia-Ye Liu, Jun-Qing Luan, Fu-Sheng Wang, Junliang Fu

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis